Prof Stephen Rose

Probing Biosystems Future Science Platform Leader

Contact details:

Biography

Research Profile:
Professor Rose is a Senior Principal Research Fellow within The Commonwealth Scientific and Industrial Research Organisation (CSIRO) – Health and Biosecurity business unit – and Director of the Probing Biosystems Future Science Platform (FSP). This FSP is focused on developing innovative medical technology to improve health and wellbeing. He is also holds an honorary Professorial title at the University of Queensland’s Centre for Clinical Research, a major translational research facility located within the Royal Brisbane and Women’s Hospital (RBWH) research precinct.

Prof Rose currently leads a $35m R&D program to drive innovation in the Medical Technologies and Pharmaceuticals sector. This includes development of the next generation of smart wearable and implantable biosensors, novel diagnostics and point-of-care medical devices for improved disease detection, monitoring and health surveillance. New emerging technologies involving living model systems to accelerate pharmaceutical development are also being targeted in this program. On a personal level, he is well recognized as a leader in medical imaging research as evidenced by his significant research track record, extensive collaborative network, and invited membership of MRFF, NHMRC fellowship and grant review panels. During his career, he has contributed to the development and translation of innovative medical imaging technologies enabling more effective delivery of diagnostic and treatment planning services, improved patient outcomes and streamlining patient workflows. Prof Rose works closely with clinicians and allied health workers developing the next generation of molecular imaging platforms targeting oncology, neurodegenerative and brain development disorders. Prof Rose also leads an innovative research program in the emerging field theranostics, developing novel biomolecular platforms for improved delivery of therapeutic targets to cancer cells in vivo.

During this career, Prof Rose has made a significant contribution to obtaining competitive funding from various NHMRC funding initiatives ($12M), grants from the ARC and various Research foundations ($6.5M), Queensland Government initiatives ($6M), international pharmaceutical industry ($10.5M) and medical service providers ($5.1m). Prof Rose significantly contributed to gaining $3.5M from the Queensland State Government to help fund state-of-the-art clinical imaging technology within Herston Imaging Research Facility (HIRF), namely the first clinical hybrid PET/MRI scanner installed in Australia. He also received funding from the Australian Cancer Research Foundation ($2m) to install a new clinical PET/CT scanner within HIRF. Prof Rose has supervised 6 PhD students as principal supervisor (4 to completion, 2 undergoing thesis review) and an additional 7 PhD students in an associate supervisory role over the last 5 years. He has published more than 230 manuscripts in international peer reviewed journals. In terms of general citation indices, his work has been cited 7454 times and his h-index is 41. Prof Rose is an invited member of the NHMRC Grants Review Panel (2010-15, 18).

Publications

We have publications by Prof Stephen Rose